Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Can the "seek, test, treat, and retain" strategy be effective in France?
Cuzin L, Allavena C, Pugliese P, Rey D, Hoen B, Poizot-Martin I, Cabie A, Yazdanpanah Y; DATʼAIDS Study Group. Cuzin L, et al. J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):e119-21. doi: 10.1097/QAI.0b013e3182809f08. J Acquir Immune Defic Syndr. 2013. PMID: 23933718 No abstract available.
Endothelial cell dysfunction in HIV infection.
Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, Gastaut JA. Lafeuillade A, et al. J Acquir Immune Defic Syndr (1988). 1992;5(2):127-31. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1531074
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients.
Allavena C, Ferré V, Brunet-François C, Delfraissy JF, Lafeuillade A, Valantin MA, Bentata M, Michelet C, Poizot-Martin I, Dailly E, Launay O, Raffi F; Bitherapy Kaletra-Sustiva Study Group. Allavena C, et al. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):300-6. doi: 10.1097/01.qai.0000165914.42827.bb. J Acquir Immune Defic Syndr. 2005. PMID: 15980689 Clinical Trial.
[The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals].
Agher R, Duvivier C, Katlama C, Gérard Y, Yazdanpanah Y, Billaud E, Jovelin T, Raffi F, Enel P, Poizot-Martin I, Puglièse P, Dellamonica P, Barone M, Cuzin L, Marchou B; Groupe Nadis. Agher R, et al. Med Mal Infect. 2005 Jul-Aug;35(7-8):407-10. doi: 10.1016/j.medmal.2005.06.004. Med Mal Infect. 2005. PMID: 16139459 French.
Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial.
Launay O, Durier C, Desaint C, Silbermann B, Jackson A, Pialoux G, Bonnet B, Poizot-Martin I, Gonzalez-Canali G, Cuzin L, Figuereido S, Surenaud M, Ben Hamouda N, Gahery H, Choppin J, Salmon D, Guérin C, Bourgault Villada I, Guillet JG; ANRS VAC16 Study Group. Launay O, et al. PLoS One. 2007 Aug 22;2(8):e725. doi: 10.1371/journal.pone.0000725. PLoS One. 2007. PMID: 17712402 Free PMC article. Clinical Trial.
356 results